Volume XXXII, No. 5 – March 31, 2025
In this issue:
In the fourth and final article in the series, The Dark Report discusses ways to use price transparency during pathology contract talks. Also, global IVD companies issue their fourth quarter earnings reports showing a mixed bag of results.